Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Validation of a proteomic biomarker panel to diagnose minor-stroke and transient ischaemic attack: phase 2 of SpecTRA, a large scale translational study.

Penn AM, Bibok MB, Saly VK, Coutts SB, Lesperance ML, Balshaw RF, Votova K, Croteau NS, Trivedi A, Jackson AM, Hegedus J, Klourfeld E, Yu AYX, Zerna C, Modi J, Barber PA, Hoag G, Borchers CH; SpecTRA study group.

Biomarkers. 2018 Dec;23(8):793-803. doi: 10.1080/1354750X.2018.1499130. Epub 2018 Aug 23.

PMID:
30010432
2.

Effects of visible and UV light on the characteristics and properties of crude oil-in-water (O/W) emulsions.

Genuino HC, Horvath DT, King'ondu CK, Hoag GE, Collins JB, Suib SL.

Photochem Photobiol Sci. 2012 Apr;11(4):692-702. doi: 10.1039/c2pp05275j. Epub 2012 Feb 2.

PMID:
22297791
3.

Biosynthesis of iron and silver nanoparticles at room temperature using aqueous sorghum bran extracts.

Njagi EC, Huang H, Stafford L, Genuino H, Galindo HM, Collins JB, Hoag GE, Suib SL.

Langmuir. 2011 Jan 4;27(1):264-71. doi: 10.1021/la103190n. Epub 2010 Dec 6.

PMID:
21133391
4.

The dietary supplement 5-hydroxytryptophan and urinary 5-hydroxyindole acetic acid.

Preshaw RM, Leavitt D, Hoag G.

CMAJ. 2008 Apr 8;178(8):993. doi: 10.1503/cmaj.071569. No abstract available.

5.

Degradation of volatile organic compounds with thermally activated persulfate oxidation.

Huang KC, Zhao Z, Hoag GE, Dahmani A, Block PA.

Chemosphere. 2005 Oct;61(4):551-60. Epub 2005 Apr 12.

PMID:
16202809
6.

Kinetics of heat-assisted persulfate oxidation of methyl tert-butyl ether (MTBE).

Huang KC, Couttenye RA, Hoag GE.

Chemosphere. 2002 Oct;49(4):413-20.

PMID:
12365838
7.

Atmospheric mercury monitoring survey in Beijing, China.

Liu S, Nadim F, Perkins C, Carley RJ, Hoag GE, Lin Y, Chen L.

Chemosphere. 2002 Jul;48(1):97-107.

PMID:
12137064
8.

Kinetics and mechanism of oxidation of tetrachloroethylene with permanganate.

Huang KC, Hoag GE, Chheda P, Woody BA, Dobbs GM.

Chemosphere. 2002 Feb;46(6):815-25.

PMID:
11922062
9.

Long-term investigation of atmospheric mercury contamination in Connecticut.

Nadim F, Perkins C, Liu S, Carley RJ, Hoag GE.

Chemosphere. 2001 Nov;45(6-7):1033-43.

PMID:
11695580
10.

The mechanism and applicability of in situ oxidation of trichloroethylene with Fenton's reagent.

Chen G, Hoag GE, Chedda P, Nadim F, Woody BA, Dobbs GM.

J Hazard Mater. 2001 Oct 12;87(1-3):171-86.

PMID:
11566408
11.

Oxidation of chlorinated ethenes by potassium permanganate: a kinetics study.

Huang KC, Hoag GE, Chheda P, Woody BA, Dobbs GM.

J Hazard Mater. 2001 Oct 12;87(1-3):155-69.

PMID:
11566407
12.

Clinical practice guidelines for treatment of diabetes mellitus.

Rasaiah B, Garg A, Hoag G.

CMAJ. 1993 Feb 15;148(4):488, 490-1. No abstract available.

14.
15.

Guidelines for a phlebotomy chair.

Rasaiah B, Hoag G.

CMAJ. 1992 Jan 15;146(2):108-9. No abstract available.

16.

The optimum urine collections for the detection and monitoring of Bence Jones proteinuria.

Brigden ML, Neal ED, McNeely MD, Hoag GN.

Am J Clin Pathol. 1990 May;93(5):689-93.

PMID:
2327368
17.

Position statement of the CSCC and CAP Task Force on the measurement of lipids for the assessment of risk of CHD.

Dinwoodie A, Frohlich J, Hoag G, Luxton AW, McQueen M, Rasaiah B, Salkie ML.

Clin Biochem. 1989 Jun;22(3):231-7. No abstract available.

PMID:
2736775
18.

Erythrocyte abnormalities in a hypoalphalipoproteinemia syndrome resembling fish eye disease.

Godin DV, Garnett ME, Hoag G, Wadsworth LD, Frohlich J.

Eur J Haematol. 1988 Aug;41(2):176-81.

PMID:
3410011
19.

Marked fall in high-density lipoprotein following isotretinoin therapy: report of a case in a weight lifter on anabolic steroids.

Hoag GN, Connolly VP, Domke HL.

J Am Acad Dermatol. 1987 Jun;16(6):1264-5. No abstract available.

PMID:
3474246
20.

Renal cell carcinoma and vasculitis: report of two cases.

Hoag GN.

J Surg Oncol. 1987 May;35(1):35-8.

PMID:
3573771
21.

Shy-Drager syndrome: the transitional variant.

Sima AA, Hoag G, Rozdilsky B.

Clin Neuropathol. 1987 Mar-Apr;6(2):49-54.

PMID:
3594975
22.

Renal carcinoma with hypercoagulability.

Rayner DC, Hoag GN, Khan TA.

Br J Urol. 1987 Jan;59(1):96. No abstract available.

PMID:
3828699
23.

Hypoalphalipoproteinemia resembling fish eye disease.

Frohlich J, Hoag G, McLeod R, Hayden M, Godin DV, Wadsworth LD, Critchley JD, Pritchard PH.

Acta Med Scand. 1987;221(3):291-8.

PMID:
3591467
24.

Malignant intracranial fibrous histiocytomas. Histologic, ultrastructural and immunohistochemical studies of two cases.

Sima AA, Ross RT, Hoag G, Rozdilsky B, Diocee M.

Can J Neurol Sci. 1986 May;13(2):138-45.

PMID:
3013388
25.

Astroblastoma revisited: a report of three cases.

Hoag G, Sima AA, Rozdilsky B.

Acta Neuropathol. 1986;70(1):10-6.

PMID:
3727930
26.

Ossified skeletal muscle angioma: report of two cases.

Hoag GN, Murphy MM, Major PA.

J Surg Oncol. 1984 Jan;25(1):34-7.

PMID:
6420620
27.

Mucinous cystadenoma of the appendix: a case report of the diagnoses and management.

Hoag GN, Thompson D, Chochinov H.

J Surg Oncol. 1983 Nov;24(3):205-8.

PMID:
6632907
28.

Hepatic infarction: biochemical study of a case.

Hoag GN, Orr TP, Amies DR.

Clin Chem. 1983 Oct;29(10):1850-1.

29.

Creatine kinase isoenzyme patterns in neoplasms of peripheral nerve.

Balaton J, Hoag GN, Franks CR, Smith CR, DeCoteau WE.

Clin Chem. 1980 Dec;26(13):1888-9.

30.

Creatine kinase isoenzyme patterns in normal smooth muscle and smooth muscle neoplasms.

Hoag GN, Franks CR, Smith C, DeCoteau WE.

Clin Biochem. 1980 Aug;13(4):149-50.

PMID:
7449081
31.

Creatine kinase isoenzymes in testicular tissue of normal subjects and in a case of lymphoblastic lymphosarcoma.

Hoag GN, Singh R, Franks CR, DeCoteau WE.

Clin Chem. 1980 Aug;26(9):1360-1. No abstract available.

PMID:
6893170
32.

Creatine kinase isoenzymes in serum of patients with cancer of various organs.

Hoag GN, Franks CR, DeCoteau WE.

Clin Chem. 1978 Sep;24(9):1654. No abstract available.

33.
34.

Alaskan Malamute chondrodysplasia. V. Decreased gut zinc absorption.

Brown RG, Hoag GN, Smart ME, Mitchell LH.

Growth. 1978 Mar;42(1):1-6.

PMID:
669395
35.

Alaskan malamute chondrodysplasia VI. Copper absorption studies.

Hoag GN, Brown RG, Smart ME, Subden RE, Mitchell LH.

Can Vet J. 1977 Dec;18(12):349-51. No abstract available.

36.
37.

Alaskan malamute chondrodysplasia IV. Concentrations of zinc, copper and iron in various tissues.

Brown RG, Hoag GN, Smart ME, Boechner G, Subden RE.

Growth. 1977 Sep;41(3):215-20.

PMID:
914057
38.

Alaskan Malamute chondrodysplasia III. Connective tissue of bone.

Brown RG, Hoag GN, Subden RE, Smart ME.

Growth. 1977 Sep;41(3):207-14.

PMID:
914056
40.

Urinary p-tyramine in hereditary tyrosinemia: II. Origin of urinary p-tyramine.

Hoag GN, Hill A, Zaleski W.

Clin Biochem. 1977 Feb;10(1):26-8.

PMID:
837523
42.

Alaskan malamute chondrodysplasia. I. Bone composition studies.

Hoag GN, Brown RG, Smart ME, Subden RE.

Growth. 1976 Mar;40(1):3-11.

PMID:
1261875
43.
44.

The investigation of aromatic acids in phenylketonuria, alkaptonuria and tyrosinosis using gas-liquid chromatography.

Hill A, Hoag GN, Zaleski WA.

Clin Chim Acta. 1972 Mar;37:455-62. No abstract available.

PMID:
5022110

Supplemental Content

Support Center